The 健康寿命研究所 is transforming the experience of ageing. We’re the UK’s first interdisciplinary research institute dedicated to understanding and preventing multimorbidity and frailty - to help everyone live healthier lives for longer.
Our rate of ageing is variable and malleable
From the moment we are conceived there are factors that influence how we age. These include the social and economic environments we live and work in, as well as our individual biology and behaviour. Our rate of ageing predicts our health span, i.e. the number of years we can expect to live an independent, healthy life. The slower our rate of ageing, the more resilient we are to multimorbidity, the presence of two or more chronic health conditions, 是什么导致了脆弱, and low quality of life in later years.
At the 健康寿命研究所, we are developing interventions across the lifecourse that slow down the rate of ageing to increase resilience to age related-disease.
Preventing multimorbidity and frailty
We’re pioneering new medical treatments, health and social care policies and public health guidance across the lifespan, to help people age better and have healthier, more independent lives for longer.
A 19-year-old is the youngest person to be diagnosed with Alzheimer’s disease – the cause is a mystery
A 19-year-old man from China, who has been having memory problems since the age of 17, was diagnosed with dementia, according to a recent case study published in the Journal of Alzheimer’s Disease.Published by The Conversation
Join us for The Art of Healthy Lifespans
Join us at The Art of Healthy Lifespans for a series of inclusive events and exhibitions showcasing the role of art and creativity in understanding and enhancing health and well-being across the life course.
New task force of international researchers to understand the role of ageing in Parkinson’s Disease
研究人员 from 29 institutions, 横跨11个国家, will join forces in a new network funded by the Michael J Fox Foundation for Parkinson’s 研究 to identify the best models to study the effect of ageing in Parkinson’s Disease development.